Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma

Código QR

Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma

BackgroundEsophageal squamous cell carcinoma (ESCC) is the most common type of esophageal cancer and the seventh most prevalent cause of cancer-related death worldwide. Tumor microenvironment (TME) has been confirmed to play an crucial role in ESCC progression, prognosis, and the response to immunot...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jiannan Yao, Ling Duan, Xuying Huang, Jian Liu, Xiaona Fan, Zeru Xiao, Rui Yan, Heshu Liu, Guangyu An, Bin Hu, Yang Ge
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	Esophageal squamous cell carcinoma tumor microenvironment prognostic biomarker immunotherapy M2 macrophage Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/4a9b277ce81042b7883097be6ecfbd13
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma – Mini Review
por: Shi Y, et al.
Publicado: (2021)

Predicting the Prognosis of Esophageal Adenocarcinoma by a Pyroptosis-Related Gene Signature
por: Ruijie Zeng, et al.
Publicado: (2021)

Characterization of Esophageal Microbiota in Patients With Esophagitis and Esophageal Squamous Cell Carcinoma
por: Zongdan Jiang, et al.
Publicado: (2021)

Identification of Hypoxia-Related Molecular Classification and Associated Gene Signature in Oral Squamous Cell Carcinoma
por: Chen Li, et al.
Publicado: (2021)

Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics study based on TCGA database
por: Danlei Song, et al.
Publicado: (2021)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Guangdi Chu, et al.
Publicado: (2021)

Relation Between Tumor Budding and Endoscopic Classification, Degree of Malignancy in T1 Stage Esophageal Squamous Cell Carcinoma
por: WANG Kang, et al.
Publicado: (2021)

Combination of Endoscopic Resection and Radiofrequency Ablation for the Treatment of Esophageal Squamous Cell Neoplasia With Multiple Lugol-Voiding Lesions
por: Zhihao Chen, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors
por: Chao Zhu, et al.
Publicado: (2021)

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
por: Yuan Chen, et al.
Publicado: (2021)

Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
por: Pingfei Tang, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
por: Hongfu Cai, et al.
Publicado: (2021)

Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis‐related genes
por: Xiayao Diao, et al.
Publicado: (2021)

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Fangdie Ye, et al.
Publicado: (2021)

New Trend of Surgery in Locally Advanced Esophageal Squamous Cell Carcinoma Patients
por: Tatcha Rerkrak, et al.
Publicado: (2021)

Advances and challenges in the treatment of esophageal cancer
por: Shiming He, et al.
Publicado: (2021)

Dysregulated circular RNAs as novel biomarkers in esophageal squamous cell carcinoma: a meta‐analysis
por: Chengcheng Guo, et al.
Publicado: (2021)

A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma
por: Shi X, et al.
Publicado: (2021)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Jerry Polesel, et al.
Publicado: (2021)

Gene Signatures and Cancer-Immune Phenotypes Based on m6A Regulators in Breast Cancer
por: Guanghui Zhao, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Yumei Fan, et al.
Publicado: (2021)

Durable Complete Response to Pembrolizumab in Esophageal Squamous Cell Carcinoma With Divergent Microsatellite Status: A Case Report
por: Tian Zeng, et al.
Publicado: (2021)

Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma
por: Ke Shi, et al.
Publicado: (2021)

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Amy J. Petty, et al.
Publicado: (2021)

Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma
por: Li Mengyan, et al.
Publicado: (2021)

Development and Evaluation of Serum CST1 Detection for Early Diagnosis of Esophageal Squamous Cell Carcinoma
por: Wang J, et al.
Publicado: (2021)

Identification of prognostic hypoxia-related genes signature on the tumor microenvironment in esophageal cancer
por: Linlin Tan, et al.
Publicado: (2021)

Worst Pattern of Perineural Invasion Redefines the Spatial Localization of Nerves in Oral Squamous Cell Carcinoma
por: Yong Fu, et al.
Publicado: (2021)

PD-1 inhibitors versus chemotherapy as second-line treatment for advanced esophageal squamous cell carcinoma: a meta-analysis
por: Xinxin Zhu, et al.
Publicado: (2021)

Prognostic Significance of Tumor-Associated Macrophages in Chondroblastoma and Their Association with Response to Adjuvant Radiotherapy
por: Zheng BW, et al.
Publicado: (2021)

A multi‐omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma
por: Xing Jin, et al.
Publicado: (2021)

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence
por: Jason Chia‐Hsun Hsieh, et al.
Publicado: (2021)

Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?
por: Patricia Martin-Romano, et al.
Publicado: (2021)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Yan Zhang, et al.
Publicado: (2021)

Epigenetic Regulator KDM4D Restricts Tumorigenesis via Modulating SYVN1/HMGB1 Ubiquitination Axis in Esophageal Squamous Cell Carcinoma
por: Wenjian Yao, et al.
Publicado: (2021)

PAR1 and PAR4 exert opposite effects on tumor growth and metastasis of esophageal squamous cell carcinoma via STAT3 and NF-κB signaling pathways
por: Jia Zhao, et al.
Publicado: (2021)

Establishment and validation of an individualized macrophage-related gene signature to predict overall survival in patients with triple negative breast cancer
por: Peng Su, et al.
Publicado: (2021)

Pushing Past the Blockade: Advancements in T Cell-Based Cancer Immunotherapies
por: Jessica Waibl Polania, et al.
Publicado: (2021)

Prognostic Impact of Tumor-Associated Macrophages on Long-Term Oncologic Outcomes in Colorectal Cancer
por: Hyeong Chan Shin, et al.
Publicado: (2021)

Survival-associated N6-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification
por: Jialin Qu, et al.
Publicado: (2021)